AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2018
Nov 15, 2018
33510_dirs_2018-11-15_68929a8b-79e0-40c3-89a7-7b9a5cb21cde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-11-14
Reporting Person: Woods Lori A (Director, Interim CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-14 | Common Stock | P | 125000 | $0.39790 | Acquired | 125000 | Direct |
| 2018-11-15 | Common Stock | P | 4365 | $0.3990 | Acquired | 129365 | Direct |
| 2018-11-15 | Common Stock | P | 635 | $0.39660 | Acquired | 130000 | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16